Acute effects of ivabradine on dynamic obstruction of the left ventricular outflow tract in cats with preclinical hypertrophic cardiomyopathy

Journal of Veterinary Internal Medicine

Volumn 28, Issue 3, 2014, Pages 838-846

  Blass, K A ^a   Schober, K E ^a   Li, X ^b   Scansen, B A ^a   Bonagura, J D ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Atenolol; Feline; Systolic anterior motion

Indexed keywords

ATENOLOL; BENZAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOTONIC AGENT; IVABRADINE;

ANIMAL; CARDIOMYOPATHY, HYPERTROPHIC; CAT; CAT DISEASES; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; MALE; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; VETERINARY;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ATENOLOL; BENZAZEPINES; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOTONIC AGENTS; CAT DISEASES; CATS; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; FEMALE; MALE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84899622247     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/jvim.12331     Document Type: Article

References (29)

1. Ferasin L, Sturgess CP, Cannon MJ, et al. Feline idiopathic cardiomyopathy: A retrospective study of 106 cats (1994-2001). J Feline Med Surg 2003;5:151-159.
2. Fox P, Liu S, Maron B. Echocardiographic assessement of spontaneously occurring feline hypertrophic cardiomyopathy. An animal model of human disease. Circulation 1995;92:2645-2651.
3. Maron M, Olivotto I, Betocchi S, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003;348:295-303.
4. Rush J, Freeman L, Fenollosa N, et al. Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990-1999). J Am Vet Med Assoc 2002;220(2):202-207.
5. Payne J, Luis Fuentes V, Boswood A, et al. Population characteristics and survival in 127 referred cats with hypertrophic cardiomyopathy (1997 to 2005). J Small Anim Pract 2010;51(10):540-547.
6. Schober KE, Zientek J, Li X, et al. Effect of treatment with atenolol on 5-year survival in cats with preclinical (asymptomatic) hypertrophic cardiomyopathy. J Vet Cardiol 2013;15:93-104.
7. Fox P. Evidence for or against efficacy of beta-blockers and aspirin for managment of feline cardiomyopathies. Vet Clin North Am Small Anim Pract 1991;21(5):1011-1022.
8. Riccioni G. Ivabradine: From molecular basis to clinical effectiveness. Adv Ther 2010;27(3):160-167.
9. Riesen S, Schober K, Smith D, et al. Effects of ivabradine on heart rate and left ventricular function in healthy cats and cats with hypertrophic cardiomyopathy. Am J Vet Res 2011;73:202-212.
10. Riesen S, Schober K, Cervenec R, et al. Comparison of the effects of ivabradine and atenolol on heart rate and echocardiographic variables of left heart function in healthy cats. J Vet Intern Med 2011;25:469-476.
11. Riesen S, Ni W, Carnes C, et al. Pharmacokinetics of oral ivabradine in healthy cats. J Vet Pharmacol Ther 2011;34(5):469-475.
12. Cober R, Schober K, Buffington C, et al. Pharmacodynamic effects of ivabradine, a negative chronotropic agent, in healthy cats. J Vet Cardiol 2011;13(4):231-242.
13. Riesen S, Schober K, Cervenec R, et al. Effects of treatment with ivabradine and atenolol on reproducibility of echocardiographic indices of left heart size and function in healthy cats. J Vet Cardiol 2012;14(2):323-332.
14. Klues H, Roberts W, Maron B. Morphological determinants of echocardiographic patterns of mitral valve systolic anterior motion in obstructive hypertrophic cardiomyopathy. Circulation 1993;87:1570-1579.
15. Thomas W, Gaber C, Jacobs GJ, et al. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. J Vet Intern Med 1993;7:247-252.
16. Bonagura J. Feline echocardiography. J Feline Med Surg 2000;2(3):147-151.
17. Brown S, Atkins C, Bagley R, et al. Guidelines for the identification, evaluation, and managment of systemic hypertension in dogs and cats. J Vet Intern Med 2007;21(3):542-558.
18. Marwick TH, Nakatani S, Haluska B, et al. Provocation of latent left ventricular outflow tract gradients with amyl nitrite and exercise in hypertrophic cardiomyopathy. Am J Cardiol 1995;75(12):805-809.
19. Sheikh K, Pearce F, Kisslo J. Use of Doppler echocardiography and amyl nitrite inhalation to characterize left ventricular outflow obstruction in hypertrophic cardiomyopathy. Chest 1990;97(2):389-395.
20. Helmcke F, Nanda N, Hsiung M, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987;75:175-183.
21. Schober K, Maerz I. Doppler echocardiographic assessment of left atrial appendage flow velocities in normal cats. J Vet Cardiol 2005;7:15-25.
22. Yoganathan A, Lemmon J Jr, Kim Y, et al. A three-dimensional computational investigation of intraventricular fluid dynamics: Examination into the initiation of systolic anterior motion of the mitral valve leaflets. J Biomech Eng 1995;117(1):94-102.
23. Sherrid M. Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2000;36:1344-1354.
24. Levine RA, Vlahakes GJ, Lefebvre X, et al. Papillary muscle displacement causes systolic anterior motion of the mitral valve: Experimental validation and insights into the mechanism of subaortic obstruction. Circulation 1995;91:1189-1195.
25. Cape E, Simons D, Jimoh A, et al. Chordal geometry determines the shape and extent of systolic anterior motion: In vitro studies. J Am Coll Cardiol 1989;13(6):1438-1448.
26. Sherrid M, Pearle G, Gunsburgh D. Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy. Circulation 1998;97:41-47.
27. Salisbury P, Cross C, Rieben P. Chorda tendinae tension. Am J Physiol 1963;205:385-392.
28. Joshi S, Patel U, Yao S-S, et al. Standing and exercise Doppler echocardiography in obstructive hypertrophic cardiomyopathy: The range of gradients with upright activity. J Am Soc Echocardiogr 2011;24(1):75-82.
29. Cabrera-Bueno F, García-Pinilla J, Gómez-Doblas J, et al. Beta-blocker therapy for dynamic left ventricular outflow tract obstruction induced by exercise. Int J Cardiol 2007;117(2):222-226.